Production (Stage)
Sanara MedTech Inc.
SMTI
$29.00
-$0.31-1.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -129.25% | 46.16% | 18.44% | -98.62% | -643.76% |
| Total Depreciation and Amortization | 2.07% | -0.21% | -0.14% | 0.01% | 0.97% |
| Total Amortization of Deferred Charges | 0.00% | 20.28% | -49.59% | 3,054.84% | 0.00% |
| Total Other Non-Cash Items | 180.97% | -49.87% | -3.51% | 95.90% | 198.35% |
| Change in Net Operating Assets | -797.18% | -81.29% | 263.59% | 43.19% | -192.83% |
| Cash from Operations | -314.47% | -54.55% | 245.23% | 11.45% | -87.91% |
| Capital Expenditure | -2,285.87% | -693.41% | 84.52% | 10.64% | -21.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5,985.12% | 99.09% | -- | -- | -- |
| Cash from Investing | -3,884.54% | 97.96% | -10,711.39% | 10.64% | -21.18% |
| Total Debt Issued | -- | -100.00% | 7.89% | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 93.50% | -51.42% | -284.40% | 165.29% | -937.48% |
| Cash from Financing | 1,098.28% | -108.32% | 201.15% | 827.50% | -254.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,305.69% | -103.94% | 204.83% | 243.26% | -113.01% |